Meta-analysis
Christoph U. Correll, MD; Jose M. Rubio, MD; Gabriella Inczedy-Farkas, MD; et al.
free access
JAMA Psychiatry. 2017;74(7):675-684. doi:10.1001/jamapsychiatry.2017.0624
This meta-analysis compares the multiple pharmacologic combination strategies that have been studied for suboptimal treatment responses in schizophrenia to facilitate decision making.
-
Invited Commentary
A Meta View on Meta-analyses
W. Wolfgang Fleischhacker, MD
JAMA Psychiatry
Jari Tiihonen, MD, PhD; Ellenor Mittendorfer-Rutz, PhD; Maila Majak, MSc; et al.
free access
JAMA Psychiatry. 2017;74(7):686-693. doi:10.1001/jamapsychiatry.2017.1322
This database study uses a nationwide cohort to examine the comparative real-world effectiveness of antipsychotic treatments for patients with schizophrenia.
Meta-analysis
Daniel Thomas Chung; Christopher James Ryan, MBBS, MHL, FRANZCP; Dusan Hadzi-Pavlovic, BSc, MPsychol; et al.
free access
JAMA Psychiatry. 2017;74(7):694-702. doi:10.1001/jamapsychiatry.2017.1044
This meta-analysis quantifies the rates of suicide after discharge from psychiatric facilities and examines what moderates those rates.
Joseph F. Hayes, MB, ChB, MSc; David P. J. Osborn, PhD; Glyn Lewis, PhD; et al.
free access
JAMA Psychiatry. 2017;74(7):703-711. doi:10.1001/jamapsychiatry.2017.0583
This longitudinal nationwide cohort study determines the association of the adolescent personality domains of social maturity, mental energy, and emotional stability with later diagnosis of serious mental illness among Swedish men.
Archana Singh-Manoux, PhD; Aline Dugravot, MSc; Agnes Fournier, PhD; et al.
free access
has audio
JAMA Psychiatry. 2017;74(7):712-718. doi:10.1001/jamapsychiatry.2017.0660
This cohort study characterizes the trajectory of depressive symptoms over 28 years prior to dementia diagnosis to determine whether depressive symptoms carry risk for dementia.
-
Podcast:
Trajectories of Depressive Symptoms Before Diagnosis of Dementia (JAMA Psychiatry)
-
Editorial
Late-Life Depression and the Prodromes of Dementia
David Carl Steffens, MD, MHS
JAMA Psychiatry
Julie R. Larsen, MD; Louise Vedtofte, PhD; Mathilde S. L. Jakobsen, MD; et al.
free access
JAMA Psychiatry. 2017;74(7):719-728. doi:10.1001/jamapsychiatry.2017.1220
This randomized clinical trial investigates the effect of liraglutide added to clozapine or olanzapine treatment of schizophrenia spectrum disorders in patients with prediabetes who are overweight or obese.
Meta-analysis
Marnix J. M. van Agtmaal, MD; Alfons J. H. M. Houben, PhD; Frans Pouwer, PhD; et al.
free access
JAMA Psychiatry. 2017;74(7):729-739. doi:10.1001/jamapsychiatry.2017.0984
This systematic review and meta-analysis examines the associations of the peripheral and cerebral forms of microvascular dysfunction with late-life depression.
Sonja Orlovska, MD; Claus Høstrup Vestergaard, MSc; Bodil Hammer Bech, PhD; et al.
free access
JAMA Psychiatry. 2017;74(7):740-746. doi:10.1001/jamapsychiatry.2017.0995
This population-based cohort study investigates the risk of mental disorders, specifically obsessive-compulsive disorder and tic disorders, after a streptococcal throat infection.
Greta A. Bushnell, MSPH; Til Stürmer, MD, PhD; Bradley N. Gaynes, MD, MPH; et al.
free access
JAMA Psychiatry. 2017;74(7):747-755. doi:10.1001/jamapsychiatry.2017.1273
This study examines simultaneous new benzodiazepine and antidepressant use among adults with depression, antidepressant treatment length by simultaneous new use status, subsequent long-term benzodiazepine use in those taking both an antidepressant and a benzodiazepine, and determinants of simultaneous new use and long-term benzodiazepine use.